PD-L1 Antibody from FORTIS LIFE SCIENCES

Search, find, compare suppliers for anti-PD-L1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPD-L1
Clonemonoclonal
Host SpeciesRecombinant Rabbit
Reactive Speciesmouse
Isotypen/a
Formatpurified
Size20 µl (2 blots)
Concentration1000 µg/ml
ApplicationsWB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRabbit anti-PD-L1 Recombinant Monoclonal Antibody [BLR226K]. PD-L1 is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. PD-L1 is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma [taken from NCBI Entrez Gene (Gene ID: 55193)].
ImmunogenEpitope: residues 19-239 (ECD)
Other NamesPdcd1lg1; B7 homolog 1; programmed cell death 1 ligand 1; PD-L1; Programmed death ligand 1; Pdl1; Pdcd1l1; PDCD1 ligand 1; CD antigen CD274; B7h1; A530045L16Rik; B7-H1
Gene, Accession #Gene ID: 60533, Accession: NP_068693.1, UniProt: Q9EP73
Catalog #A700-226-T
Price$127
Order / More InfoPD-L1 Antibody from FORTIS LIFE SCIENCES
Product Specific Referencesn/a
FORTIS LIFE SCIENCES
FORTIS LIFE SCIENCES
FORTIS LIFE SCIENCES
1440 Main Street, Suite 300
Waltham MA 02451
P: 800.338.9579

info@fortislife.com

https://www.fortislife.com

Profile of FORTIS LIFE SCIENCES
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.